Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NAV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ESR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928973 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101927133 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NXPH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXB-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYRK1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELMO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PON2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
INPP5D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARSK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GKN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00330 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF2IRD2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K14-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on